Cite

HARVARD Citation

    Mangraviti, A. et al. (2017). HIF-1α- Targeting Acriflavine Provides Long Term Survival and Radiological Tumor Response in Brain Cancer Therapy. Scientific reports. 7 (1), pp. 1-13. [Online]. 
  
Back to record